[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1256814A1 - 用於在藥物中使用的膠體顆粒 - Google Patents

用於在藥物中使用的膠體顆粒

Info

Publication number
HK1256814A1
HK1256814A1 HK18115899.0A HK18115899A HK1256814A1 HK 1256814 A1 HK1256814 A1 HK 1256814A1 HK 18115899 A HK18115899 A HK 18115899A HK 1256814 A1 HK1256814 A1 HK 1256814A1
Authority
HK
Hong Kong
Prior art keywords
medicine
colloidal particles
colloidal
particles
Prior art date
Application number
HK18115899.0A
Other languages
English (en)
Inventor
William Henry
Richard Wolf-Garraway
John Mayo
Original Assignee
Cantab Biopharmaceuticals Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd
Publication of HK1256814A1 publication Critical patent/HK1256814A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18115899.0A 2015-10-14 2018-12-11 用於在藥物中使用的膠體顆粒 HK1256814A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1518172.0A GB201518172D0 (en) 2015-10-14 2015-10-14 Colloidal particles for use in medicine
PCT/EP2016/074759 WO2017064276A1 (en) 2015-10-14 2016-10-14 Colloidal particles for use in medicine

Publications (1)

Publication Number Publication Date
HK1256814A1 true HK1256814A1 (zh) 2019-10-04

Family

ID=55131025

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115899.0A HK1256814A1 (zh) 2015-10-14 2018-12-11 用於在藥物中使用的膠體顆粒

Country Status (15)

Country Link
US (2) US20190192664A1 (zh)
EP (1) EP3362039A1 (zh)
JP (1) JP7160678B2 (zh)
KR (1) KR20180067616A (zh)
CN (1) CN108472246A (zh)
AU (1) AU2016336929B2 (zh)
BR (1) BR112018007399A2 (zh)
CA (1) CA3036111C (zh)
EA (1) EA201890703A1 (zh)
GB (1) GB201518172D0 (zh)
HK (1) HK1256814A1 (zh)
IL (1) IL258567A (zh)
MX (1) MX2018004445A (zh)
SG (2) SG10202010711UA (zh)
WO (1) WO2017064276A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202111759D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles
GB202111757D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A
GB202111758D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ATE179599T1 (de) 1993-08-06 1999-05-15 Opperbas Holding Bv Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
AU747391B2 (en) 1998-04-27 2002-05-16 Cantab Biopharmaceuticals Patents Limited Pharmaceutical composition comprising factor VIII and neutral liposomes
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
CN1193059C (zh) 1999-07-14 2005-03-16 阿尔萨公司 中性脂质聚合物以及含中性脂质聚合物的脂质体组合物
US20030232075A1 (en) * 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
ES2307009T3 (es) 2003-04-15 2008-11-16 Opperbas Holding B.V. Composicion farmaceutica que contiene proteinas y/o polipeptidos y particulas coloidales.
JP2008544990A (ja) * 2005-06-29 2008-12-11 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 低免疫原性蛋白質−脂質複合体に関する組成物および方法
ES2682075T3 (es) 2009-06-03 2018-09-18 Sequessome Technology Holdings Limited Formulaciones para el tratamiento de dolor de tejido profundo
US20120232034A1 (en) 2009-08-21 2012-09-13 Henk-Andre Kroon Vesicular formulations
GB201007357D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIII
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
IN2014DN08598A (zh) 2012-04-16 2015-05-22 Cantab Biopharmaceuticals Patents Ltd
CN107879960B (zh) * 2013-03-08 2021-06-22 诺华股份有限公司 用于传递活性成分的脂质和脂质组合物

Also Published As

Publication number Publication date
WO2017064276A1 (en) 2017-04-20
CA3036111A1 (en) 2017-04-20
US20210093721A1 (en) 2021-04-01
IL258567A (en) 2018-05-31
BR112018007399A2 (pt) 2018-10-16
AU2016336929A1 (en) 2018-05-10
CA3036111C (en) 2023-06-06
US20190192664A1 (en) 2019-06-27
GB201518172D0 (en) 2015-11-25
MX2018004445A (es) 2018-08-14
SG10202010711UA (en) 2020-12-30
CN108472246A (zh) 2018-08-31
JP7160678B2 (ja) 2022-10-25
JP2018535952A (ja) 2018-12-06
EP3362039A1 (en) 2018-08-22
EA201890703A1 (ru) 2018-11-30
SG11201802956RA (en) 2018-05-30
KR20180067616A (ko) 2018-06-20
AU2016336929B2 (en) 2022-09-29

Similar Documents

Publication Publication Date Title
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
GB2524085B (en) Exception handling in microprocessor systems
SG11201605896WA (en) Dihydropyrimidine compounds and their application in pharmaceuticals
PL3046983T3 (pl) Wielowarstwowa cząstka ścierna
SG11201700968PA (en) Formulation comprising particles
IL251630A0 (en) Combined therapy for use in cancer treatment
GB201405614D0 (en) Particles
ZA201502203B (en) Nano particulate delivery system
IL251905B (en) Epilimod for use in the treatment of kidney cancer
IL250507B (en) Anti-ck8 antibodies for use in cancer treatment
GB201412841D0 (en) Particles
IL248424B (en) Neuroprotective substances and their uses
GB201521304D0 (en) Tokenisation in cardholder - not - present transactions
EP3177304A4 (en) Therapeutic nanoparticles for accumulation in the brain
HK1256814A1 (zh) 用於在藥物中使用的膠體顆粒
PL3129057T3 (pl) Glikolipidy i ich kompozycje farmaceutyczne do stosowania w leczeniu
GB201701400D0 (en) Compound for use in medicine
SG11201606034WA (en) Device for delivering particles
GB201616880D0 (en) Compound for use in medicine
GB201516107D0 (en) Complexes and methods for their preparation
GB201701388D0 (en) Compound for use in medicine
EP3344661C0 (en) IRON POLYSACCHARIDE COMPLEXES AND METHOD FOR THE PRODUCTION THEREOF
GB201416493D0 (en) Polypeptides for use in therapy
GB201404831D0 (en) Animalistic studies in nature
GB201409978D0 (en) Novel compounds and their use in therapy